Costs and cost-effectiveness of hematopoietic cell transplantation
- PMID: 22484549
- PMCID: PMC3678555
- DOI: 10.1016/j.bbmt.2012.04.001
Costs and cost-effectiveness of hematopoietic cell transplantation
Abstract
Interest is growing in economic and comparative effectiveness analyses, with increasing emphasis on optimizing healthcare resources and costs. Limited information is available on the economic aspects of hematopoietic cell transplantation (HCT). We review contemporary literature on the costs and cost-effectiveness of HCT in the United States and worldwide. Published studies confirm the high costs associated with HCT, although the reported costs are highly variable, related to the differing methodologies used across studies. We examine the challenges in reviewing costs and cost-effectiveness across studies specific to HCT and highlight factors identified as associated with higher costs of HCT. We also discuss opportunities for future research in this area.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Pasquini MC, Wang Z, Horowitz MM, et al. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl. 2010:87–105. - PubMed
-
- Stranges E, Russo A, Friedman B. Procedures with the most rapidly increasing hospital costs, 2004–2007. [Accessed January 9, 2012];Healthcare Cost and Utilization Project (HCUP) statistical brief 82. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53597/
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
